Overview

Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025

Status:
Completed
Trial end date:
2019-05-20
Target enrollment:
Participant gender:
Summary
Human, absorption, metabolism and excretion study of belumosudil (KD025)
Phase:
Phase 1
Details
Lead Sponsor:
Kadmon Corporation, LLC
Collaborator:
Quotient Sciences